Moderna’s mRNA cancer vaccine helped prevent relapse for people with high-risk melanoma in a mid-stage trial, some of the strongest evidence yet that such vaccines could benefit patients
Moderna Inc. and Merck & Co.’s cancer vaccine helped prevent relapse for melanoma patients, results from a midstage trial showed, demonstrating progress in the pursuit of shots to ward off cancer by jump-starting the immune system.
were alive and cancer-free at 18 months, compared with about 62% of patients who received immunotherapy alone, researchers said Sunday. The 157-person trial offers some of the strongest evidence yet that such vaccines could benefit cancer patients.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Moderna cancer vaccine with Merck's Keytruda delays return of deadly skin cancerAn experimental mRNA vaccine developed by Moderna Inc combined with Merck & Co's blockbuster immunotherapy Keytruda cut the risk of death or recurrence of the most deadly skin cancer by 44% compared Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.
Leer más »
Moderna cancer vaccine with Merck's Keytruda delays return of deadly skin cancerModerna cancer vaccine with Merck’s Keytruda delays return of deadly skin cancer
Leer más »
Moderna/Merck cancer vaccine plus Keytruda delays skin cancer returnAn experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of death or recurrence of the most deadly skin cancer by 44% compared with Merck's immunotherapy Keytruda alone, U.S. researchers reported at a medical meeting on Sunday.
Leer más »
Moderna Shows Progress Toward Cancer VaccinesModerna’s mRNA cancer vaccine helped prevent relapse for melanoma patients, results from a mid-stage trial showed, demonstrating progress in the pursuit of shots to ward off cancer by jump-starting the immune system
Leer más »
'Late Late Show' addresses whether One Direction is reuniting for James Corden's final show | CNNSorry One Directioners, but a reunion is not happening on 'The Late Late Show with James Corden.'
Leer más »
Merck in late-stage talks to acquire Prometheus Biosciences -WSJMerck & Co is in late-stage talks to acquire Prometheus Biosciences Inc to get its hands on promising immune disease treatments, the Wall Street Journal reported on Sunday citing people familiar with the matter.
Leer más »